Introduction to Nonclinical Statistics for Pharmaceutical and Biotechnology Industries-Reference-Cited by-同舟云学术

Introduction to Nonclinical Statistics for Pharmaceutical and Biotechnology Industries

Published:2016 Issue: Volume: Page:3-17
ISSN:1431-8776
Container-title:Nonclinical Statistics for Pharmaceutical and Biotechnology Industries
language:
Short-container-title:

Author:

Zhang Lanju,Su Cheng

Publisher

Springer International Publishing

Link

http://link.springer.com/content/pdf/10.1007/978-3-319-23558-5_1

Reference10 articles.

1. Begley GC, Ellis LM (2012) Raise standards for preclinical cancer research. Nature 483: 531–533

2. Fisher RA (1926) The arrangement of field experiments. J Ministry Agric (G B) 33:503–513

3. Food and Drug Administration (2004) Innovation or Stagnation: Challenge and opportunity on the critical path to new medical products. Washington DC, USA

4. Grieve AP (2002) Do statisticians count? A personal view. Pharm Stat 1:35–43

5. Hill AB (1937) Principles of medical statistics. I. The aim of the statistical method. Lancet 1:41–43

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Failure rate and downtime survey of wind turbines located in Spain;IET Renewable Power Generation;2021-01

2. Classic and evolving animal models in Parkinson's disease;Pharmacology Biochemistry and Behavior;2020-12

3. Purchasing intention and behavior in the sharing economy: Mediating effects of APP assessments;Journal of Business Research;2020-12

4. The current state of Bayesian methods in nonclinical pharmaceutical statistics: Survey results and recommendations from the DIA / ASA‐BIOP Nonclinical Bayesian Working Group;Pharmaceutical Statistics;2020-10-06

5. RGFP966, a histone deacetylase 3 inhibitor, promotes glioma stem cell differentiation by blocking TGF-β signaling via SMAD7;Biochemical Pharmacology;2020-10